554 results on '"Sidonio, Robert"'
Search Results
2. Conformational activation and inhibition of von Willebrand factor by targeting its autoinhibitory module
3. von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease
4. Procedural outcomes in children with mild type 1 von Willebrand disease
5. Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial
6. Reproductive healthcare utilization in patients with bleeding disorders
7. Thrombin generation and implications for hemophilia therapies: A narrative review
8. Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations
9. von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis
10. Bleeding assessment tools in the diagnosis of VWD in adults and children: a systematic review and meta-analysis of test accuracy
11. Early diagnosis of persons with von Willebrand disease using a machine learning algorithm and real-world data
12. Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A
13. Hemophilia Carriers
14. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease
15. Adequate menstrual suppression in adolescents with inherited bleeding disorders often requires multiple treatment changes: Retrospective cohort study of a multidisciplinary clinic.
16. The spectrum and severity of bleeding in adolescents with low von Willebrand factor–associated heavy menstrual bleeding
17. Simoctocog alfa (Nuwiq®) in children: early steps in life’s journey for people with severe hemophilia A
18. A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors
19. Factor VIII stimulants and other novel therapies for the treatment of von Willebrand disease: what’s new on the horizon?
20. Nanobody activator improves sensitivity of the von Willebrand factor activity assay to multimer size
21. Unresolved hemostasis issues in haemophilia.
22. Patient‐centred research agenda for females with bleeding disorders
23. Novel therapeutics for hemophilia and other bleeding disorders
24. Aberrant splicing contributes to severe [alpha]-spectrin-linked congenital hemolytic anemia
25. Diagnostic pitfalls and conundrums in type 1 von Willebrand disease
26. Immunogenicity, safety and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A: interim results from a phase 3, prospective, multicenter, open-label study
27. Severe muscle bleeds in children and young adults with hemophilia A on emicizumab prophylaxis: Real‐world retrospective multi‐institutional cohort
28. Duration of anticoagulation for venous thromboembolism in pediatric patients: Kids-DOTT trial outcomes at 2 years
29. Chapter 5 - Acquired disorders of hemostasis
30. Von Willebrand disease: Gaining a global perspective
31. Reproductive healthcare utilization in patients with bleeding disorders
32. The emotional experience of mothers of children with haemophilia: maternal guilt, effective coping strategies and resilience within the haemophilia community
33. Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B‐LONG trial
34. Depression and anxiety in persons with Von Willebrand disease
35. RNAing toward a new therapy for hemophilia
36. A two-center retrospective review of the hematologic evaluation and laboratory abnormalities in suspected victims of non-accidental injury
37. Acquired Hypofibrinogenemia Before Asparaginase Exposure During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia: A Report of 2 Cases and Review of the Literature
38. Coagulation concentrates for inherited bleeding disorders
39. International consensus recommendations on the management of people with haemophilia B.
40. Characterization of Hysterectomy/Uterine Ablation Rates in VWD and Undiagnosed Bleeding Using Claims Data [32G]
41. Depression and anxiety in persons with Von Willebrand disease.
42. Bleeding in patients with hemophilia who have inhibitors: Modeling US medical system utilization and cost avoidance between recombinant factor VIIa products with different clinical dosing requirements
43. Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues
44. Bone health in haemophilia carriers and persons with von Willebrand disease: A large database analysis
45. Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor
46. OP031: The emotional experience of hemophilia heterozygote women: Average maternal guilt, effective coping strategies, and resilience within the hemophilia community
47. sj-docx-1-tah-10.1177_20406207221085202 – Supplemental material for International consensus recommendations on the management of people with haemophilia B
48. International consensus recommendations on the management of people with haemophilia B
49. von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis
50. Hemophilia B (Factor IX Deficiency)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.